Small-Joint Reconstructive Implants – Market Insights – United States

The US reconstructive small-joint implant market is seeing strong growth and rapid innovation in implant design, development of robotic systems for shoulder arthroplasty, and integration of digital enablement technologies. Going forward, market expansion will be driven by high growth in certain subsegments, such as those for shoulder and total ankle arthroplasty, as well as the increasing accessibility to and affordability of small-joint reconstructive implant procedures due to shift to outpatient and ASC settings.

This Medtech 360 Report provides comprehensive data and analysis on the state of the US market for small-joint reconstructive implants from 2019 through 2033.

Technological innovation will have a significant impact on the US small-joint reconstructive implant market.

What are some of the newest innovations in each segment of the small-joint reconstructive implant market?

Which segments are seeing the most product launches?

How are there innovations impacting ASP trends and market growth?

The shift to outpatient and ASC settings for small-joint reconstructive procedures will continue.

What factors are driving the shift of procedures to outpatient and ASC settings?

What are the latest CMS policy changes, and how will they impact the market?

The sizable shoulder segment continues to exhibit growth.

What factors are driving procedure volumes and revenue growth in this segment?

Which companies lead the shoulder implant segment, and what innovations are they focusing on?

Large competitors have consolidated their market share.

How are the leading competitors leveraging their positions in the market to maintain their market shares?

What strategies can smaller competitors use to gain market share?

Which product segments should competitors focus on for growth opportunities?